Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Parkinson's Disease

Interventions

DRUG

Rotigotine

"Day 1-3: 2 mg patch once daily~Day 4-6: 4 mg patch once daily"

OTHER

Placebo

"Placebo patches matching with Rotigotine 2 mg patches and 4 mg patches.~Frequency:~Day 1-3: 2 mg patch once daily~Day 4-6: 4 mg patch once daily"

Trial Locations (1)

Seoul